Back to Search
Start Over
Correspondence on 'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation’ by Braaten et al
- Source :
- Annals of the Rheumatic Diseases. 81:e13-e13
- Publication Year :
- 2020
- Publisher :
- BMJ, 2020.
-
Abstract
- We read with interest the study published by Braaten and colleagues, analysing the long-term outcomes of 60 patients developing persistent inflammatory arthritis (IA) after immune checkpoint inhibitors (ICIs) cessation. The most relevant result of the study was the presence of active arthritis in more than half of the patients at the last follow-up visit.1 We report here our experience in the context of a joint oncology/rheumatology outpatient clinic, in order to evaluate the risk of developing IA in patients treated by anti-PD1 drugs. During 1-year period, we consecutively assessed all the adult patients candidate to anti-PD1 treatment, referring to the Oncology Unit at the Sapienza University of Rome. After treatment starts, in the case of musculoskeletal manifestations, patients were referred to the Sapienza Arthritis Center, Rheumatology Unit, Sapienza University of Rome. Arthritis was defined as the occurrence of at least one episode of clinical synovitis, with morning stiffness lasting at least 30 min. …
- Subjects :
- 030203 arthritis & rheumatology
0301 basic medicine
medicine.medical_specialty
business.industry
Inflammatory arthritis
medicine.medical_treatment
Immunology
Arthritis
Context (language use)
Immunotherapy
medicine.disease_cause
medicine.disease
General Biochemistry, Genetics and Molecular Biology
Rheumatology
Autoimmunity
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Internal medicine
Synovitis
medicine
Immunology and Allergy
Outpatient clinic
business
Subjects
Details
- ISSN :
- 14682060 and 00034967
- Volume :
- 81
- Database :
- OpenAIRE
- Journal :
- Annals of the Rheumatic Diseases
- Accession number :
- edsair.doi...........38030b463bbef1100fa9c3e2b7daba1b